BillionaireNet
Jinhao
Du Jinhao
Rank #1675
CHINAHealthcarepharmaceuticals

Du Jinhao

Net Worth
$2.345B
-0.64% (24h)
Du Jinhao, a self-made billionaire, is the chairman of Shanghai Allist Pharmaceuticals, a major medicine supplier based in Shanghai, China. At 71 years old, his wealth source is rooted in the pharmaceuticals industry, driving the healthcare sector forward. Du co-founded the company in 2004, which went public on the Shanghai Stock Exchange in 2020. With a current net worth of $2.4 Billion (as of December 16, 2025), Du Jinhao has made significant career achievements and is ranked #1662 in the world. His career milestones include chairing Shanghai Allist Pharmaceuticals. He is married and resides in Shanghai, China.

The Full Dossier

Early Life

Information regarding Du Jinhao's early life and education is limited in the search results. Further research may be needed to uncover details about his formative years.

Rise to Success

Du Jinhao's rise to success is primarily attributed to his leadership as the chairman of Shanghai Allist Pharmaceuticals. He co-founded the company in 2004 and led it to become a publicly traded entity on the Shanghai Stock Exchange in 2020.

Key Business Strategies

Du Jinhao's key business strategy involves steering Shanghai Allist Pharmaceuticals, a prominent medicine supplier. The company's success is linked to its ability to supply medicine, contributing to the healthcare industry's growth. The company's IPO in 2020 was a significant strategic move.

Philanthropy

Specific details regarding Du Jinhao's philanthropic initiatives and amounts are not available in the search results. Further research would be needed.

Career Timeline

2020

Shanghai Allist Pharmaceuticals IPO

Led the company to go public on the Shanghai Stock Exchange.

2004

Co-founded Shanghai Allist Pharmaceuticals

Du Jinhao co-founded Shanghai Allist Pharmaceuticals, a medicine supplier.

Philanthropic Impact

N/AUndisclosed

Information on his philanthropic initiatives is not available in the search results.

Further research is needed.

Wealth Trajectory